Marksans Pharma has reported results for third quarter ended December 31, 2024 (Q3FY25)
The company has reported over two-fold jump in its net profit at Rs 55.46 crore for Q3FY25 as compared to Rs 25.29 crore for the same quarter in the previous year. Total income of the company increased by 37.78% at Rs 334.37 crore for Q3FY25 as compared to Rs 242.69 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 26.64% rise in its net profit at Rs 105.07 crore for the quarter ended December 31, 2024 as compared to Rs 82.97 crore for the same quarter in the previous year. Total income of the company increased by 20.10% at Rs 709.70 crore for Q3FY25 as compared to Rs 590.93 crore for the corresponding quarter previous year.
